Evidence map›Paper›PMID 29467238›Full record

ArticleMolecular pharmacology2018

Ethanol Reversal of Oxycodone Tolerance in Dorsal Root Ganglia Neurons.

Joanna C Jacob, Kensuke Sakakibara, Ryan A Mischel, Graeme Henderson, William L Dewey, Hamid I Akbarali

Open access · bronzeAbstract read
In one paragraph

Article in Molecular pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Joanna C JacobDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.C.J., K.S., R.A.M., W.L.D., H.I.A.); and School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom (G.H.) hamid.akbarali@vcuhealth.org jacobjc@vcu.edu.
Kensuke SakakibaraDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.C.J., K.S., R.A.M., W.L.D., H.I.A.); and School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom (G.H.).
Ryan A MischelDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.C.J., K.S., R.A.M., W.L.D., H.I.A.); and School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom (G.H.).
Graeme HendersonDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.C.J., K.S., R.A.M., W.L.D., H.I.A.); and School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom (G.H.).
William L DeweyDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.C.J., K.S., R.A.M., W.L.D., H.I.A.); and School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom (G.H.).
Hamid I AkbaraliDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.C.J., K.S., R.A.M., W.L.D., H.I.A.); and School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom (G.H.) hamid.akbarali@vcuhealth.org jacobjc@vcu.edu.
University of Bristol · GBVirginia Commonwealth University · US

Funding

TRAINING IN THE PHARMACOLOGY OF ABUSED DRUGST32DA007027 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI William L. Dewey · 1985 to 2026
$14.7M
VCU Center for Drug Addiction ResearchP30DA033934 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI Matthew Sean Halquist · 2014 to 2026
$13.8M
Mechanisms of Ethanol's Reversal of Opioid ToleranceR01DA036975 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI AKBARALI, HAMID I, DEWEY, WILLIAM L. · 2014 to 2018
$2.3M
Medical Research Council MR/J013269/1NIDA NIH HHS P30 DA033934NIDA NIH HHS R01 DA036975NIDA NIH HHS T32 DA007027
6 · The paper itself

Abstract

Oxycodone is a semisynthetic opioid compound that is widely prescribed, used, and abused today, and has a well-established role in shaping the current opioid epidemic. Previously, we have shown that tolerance develops to the antinociceptive and respiratory depressive effects of oxycodone in mice, and that a moderate dose of acute ethanol or a protein kinase C (PKC) inhibitor reversed that tolerance. To investigate further if tolerance was occurring through neuronal mechanisms, our aims for this study were to assess the effects of acute and prolonged oxycodone in isolated dorsal root ganglia (DRG) neurons and to determine if this tolerance was reversed by either ethanol or a PKC inhibitor. We found that an acute exposure to 3

Indexed as

Drug ToleranceAction PotentialsAnalgesics, OpioidAnimalsbeta-Arrestin 2Cells, CulturedEthanolGanglia, SpinalIndolesMaleMaleimidesMembrane PotentialsMice, Inbred C57BLMice, KnockoutNeuronsOxycodoneAnalgesics, OpioidArrb2 protein, mousebeta-Arrestin 2bisindolylmaleimideEthanolIndolesMaleimidesOxycodoneProtein Kinase CProtein Kinase Inhibitors

Identifiers

PMID29467238
PMCPMC5878666
OpenAlexW2788881667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.